110 related articles for article (PubMed ID: 10668407)
21. Comparison of the DNA binding specificity and function of v-ErbA and thyroid hormone receptor alpha 1.
Subauste JS; Koenig RJ
J Biol Chem; 1995 Apr; 270(14):7957-62. PubMed ID: 7713893
[TBL] [Abstract][Full Text] [Related]
22. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
Nagl SB; Bunn CF; Allison LA
J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
[TBL] [Abstract][Full Text] [Related]
23. Dimerization of v-erbA on inverted repeats.
Zubkova I; Subauste JS
Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
[TBL] [Abstract][Full Text] [Related]
24. Sarcoma and thyroid disorders: a common etiology?
Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
[TBL] [Abstract][Full Text] [Related]
25. Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6.
Busch K; Martin B; Baniahmad A; Martial JA; Renkawitz R; Muller M
Mol Endocrinol; 2000 Feb; 14(2):201-11. PubMed ID: 10674394
[TBL] [Abstract][Full Text] [Related]
26. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
27. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
28. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.
Ventura-Holman T; Mamoon A; Subauste MC; Subauste JS
Mol Biol Rep; 2011 Feb; 38(2):1137-44. PubMed ID: 20571909
[TBL] [Abstract][Full Text] [Related]
29. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing nuclear receptors in transcriptional repression.
Burcin M; Köhne AC; Runge D; Steiner C; Renkawitz R
Semin Cancer Biol; 1994 Oct; 5(5):337-46. PubMed ID: 7849262
[TBL] [Abstract][Full Text] [Related]
31. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
Zenke M; Muñoz A; Sap J; Vennström B; Beug H
Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
[TBL] [Abstract][Full Text] [Related]
32. The viral erbA oncogene protein, a constitutive repressor in animal cells, is a hormone-regulated activator in yeast.
Privalsky ML; Sharif M; Yamamoto KR
Cell; 1990 Dec; 63(6):1277-86. PubMed ID: 1979758
[TBL] [Abstract][Full Text] [Related]
33. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
Zubkova I; Subauste JS
Mol Cell Endocrinol; 2003 Jan; 199(1-2):61-72. PubMed ID: 12581880
[TBL] [Abstract][Full Text] [Related]
34. p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption.
Li Q; Imhof A; Collingwood TN; Urnov FD; Wolffe AP
EMBO J; 1999 Oct; 18(20):5634-52. PubMed ID: 10523307
[TBL] [Abstract][Full Text] [Related]
35. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
Smit-McBride Z; Privalsky ML
Oncogene; 1993 Jun; 8(6):1465-75. PubMed ID: 8099219
[TBL] [Abstract][Full Text] [Related]
36. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
Ghysdael J; Beug H
Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
[TBL] [Abstract][Full Text] [Related]
37. Isolation of a cDNA encoding human Rev-ErbA alpha: transcription from the noncoding DNA strand of a thyroid hormone receptor gene results in a related protein that does not bind thyroid hormone.
Lazar MA; Jones KE; Chin WW
DNA Cell Biol; 1990 Mar; 9(2):77-83. PubMed ID: 1971514
[TBL] [Abstract][Full Text] [Related]
38. Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation.
Wong J; Shi YB; Wolffe AP
EMBO J; 1997 Jun; 16(11):3158-71. PubMed ID: 9214633
[TBL] [Abstract][Full Text] [Related]
39. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M
Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217
[TBL] [Abstract][Full Text] [Related]
40. Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.
Martin B; Renkawitz R; Muller M
Nucleic Acids Res; 1994 Nov; 22(23):4898-905. PubMed ID: 7800478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
